New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study finds tafenoquine is a cost-effective treatment option for malaria

Study finds tafenoquine is a cost-effective treatment option for malaria

by Menzies School of Health ResearchMap of incremental cost-effectiveness ratios (ICERs) in each malaria-endemic municipality for Scenario 1 (tafenoquine for adults, primaquine adherence 66.7%),
Breakthroughs May 09,2024
Study finds tafenoquine is a cost-effective treatment option for malaria

Study finds tafenoquine is a cost-effective treatment option for malaria

by Menzies School of Health ResearchMap of incremental cost-effectiveness ratios (ICERs) in each malaria-endemic municipality for Scenario 1 (tafenoquine for adults, primaquine adherence 66.7%),
Breakthroughs May 09,2024
Dexmedetomidine cuts incidence of postpartum depression after C-section

Dexmedetomidine cuts incidence of postpartum depression after C-section

by Elana GotkineFor women with prenatal depression undergoing cesarean delivery, dexmedetomidine reduces the incidence of positive postpartum depression (PPD) screening, according to a studypubl
Breakthroughs May 09,2024
Dexmedetomidine cuts incidence of postpartum depression after C-section

Dexmedetomidine cuts incidence of postpartum depression after C-section

by Elana GotkineFor women with prenatal depression undergoing cesarean delivery, dexmedetomidine reduces the incidence of positive postpartum depression (PPD) screening, according to a studypubl
Breakthroughs May 09,2024
Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha
Oncology May 09,2024
Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha
Oncology May 09,2024
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Oncology May 09,2024
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Oncology May 09,2024
Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

by University of Southern CaliforniaClinician-level Opioid Prescribing. Boxplots showing median logMME, the interquartile range, and outliers pre-to-post intervention between study arms amo
Breakthroughs May 09,2024
Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

Want safer prescribing? Provide doctors with a plan for helping patients in pain, says study

by University of Southern CaliforniaClinician-level Opioid Prescribing. Boxplots showing median logMME, the interquartile range, and outliers pre-to-post intervention between study arms amo
Breakthroughs May 09,2024
Dos and don'ts developed for direct oral anticoagulants

Dos and don'ts developed for direct oral anticoagulants

by Brigham and Women’s HospitalCentral Illustration. Credit:Journal of the American College of Cardiology(2024). DOI: 10.1016/j.jacc.2023.10.038Direct oral anticoagulants (DOACs) are
Breakthroughs May 09,2024
Dos and don'ts developed for direct oral anticoagulants

Dos and don'ts developed for direct oral anticoagulants

by Brigham and Women’s HospitalCentral Illustration. Credit:Journal of the American College of Cardiology(2024). DOI: 10.1016/j.jacc.2023.10.038Direct oral anticoagulants (DOACs) are
Breakthroughs May 09,2024
Untrained bystanders can administer drone-delivered naloxone, potentially saving lives of opioid overdose victims

Untrained bystanders can administer drone-delivered naloxone, potentially saving lives of opioid overdose victims

by Nicole Adams,The ConversationDrone deliveries would be particularly effective in places where emergency responders can't respond quickly. Credit: Vincent Walter/Purdue University, CC BY-N
Breakthroughs May 09,2024
Untrained bystanders can administer drone-delivered naloxone, potentially saving lives of opioid overdose victims

Untrained bystanders can administer drone-delivered naloxone, potentially saving lives of opioid overdose victims

by Nicole Adams,The ConversationDrone deliveries would be particularly effective in places where emergency responders can't respond quickly. Credit: Vincent Walter/Purdue University, CC BY-N
Breakthroughs May 09,2024
Rutgers researchers receive funding to study perceptions of a ban on menthol cigarettes

Rutgers researchers receive funding to study perceptions of a ban on menthol cigarettes

by Aubrey Whelan, The Philadelphia InquirerCredit: Unsplash/CC0 Public DomainResearchers at Rutgers University have received more than $7 million to study disinformation and marketing around a propose
Public Health & Prevention May 09,2024
Rutgers researchers receive funding to study perceptions of a ban on menthol cigarettes

Rutgers researchers receive funding to study perceptions of a ban on menthol cigarettes

by Aubrey Whelan, The Philadelphia InquirerCredit: Unsplash/CC0 Public DomainResearchers at Rutgers University have received more than $7 million to study disinformation and marketing around a propose
Public Health & Prevention May 09,2024
Dermatologists' group offers latest guidance on acne

Dermatologists' group offers latest guidance on acne

by Ernie MundellIt might take a combination of treatments to rein in problem acne in teens and adults,updated guidelinesfrom the American Academy of Dermatology (AAD) suggest.The work appe
Dermatology May 09,2024
Dermatologists' group offers latest guidance on acne

Dermatologists' group offers latest guidance on acne

by Ernie MundellIt might take a combination of treatments to rein in problem acne in teens and adults,updated guidelinesfrom the American Academy of Dermatology (AAD) suggest.The work appe
Dermatology May 09,2024
New study points to supply chain disruptions if the FDA removes ineffective decongestant from the market

New study points to supply chain disruptions if the FDA removes ineffective decongestant from the market

by University of PittsburghCredit: Andrea Piacquadio from PexelsIn a new study of nasal decongestant purchasing patterns, researchers at the University of Pittsburgh School of Medicine found that
Breakthroughs May 09,2024
New study points to supply chain disruptions if the FDA removes ineffective decongestant from the market

New study points to supply chain disruptions if the FDA removes ineffective decongestant from the market

by University of PittsburghCredit: Andrea Piacquadio from PexelsIn a new study of nasal decongestant purchasing patterns, researchers at the University of Pittsburgh School of Medicine found that
Breakthroughs May 09,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com